# A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer

> **NCT02747342** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 33 (actual)

## Conditions studied

- Neoplasm
- Prostate Cancer

## Interventions

- **DRUG:** SHR3680; SHR3162

## Key facts

- **NCT ID:** NCT02747342
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-06-28
- **Final completion:** 2020-06-28
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02747342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02747342, "A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02747342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*